94087 ⎘
Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5 with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
COVALENT, CHEMOGENETIC ACTIVATORS FOR K2P POTASSIUM CHANNELS AND USES THEREOF
#2ORGANIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE ORGANIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND ELECTRONIC EQUIPMENT INCLUDING THE ELECTRONIC APPARATUS
#3N/O-LINKED DEGRONS AND DEGRONIMERS FOR PROTEIN DEGRADATION
#4SYSTEM AND METHOD OF WAGERING ON A PLURALITY OF EVENTS
#5Methods for Detecting Renal Disease
#6ANALOGS AND CONJUGATES OF ß-AMINOISOBUTYRIC ACID (BAIB)
#7N/O-LINKED DEGRONS AND DEGRONIMERS FOR PROTEIN DEGRADATION
#8COMPOSITIONS AND METHODS FOR VIRAL SENSITIZATION
#9N/O-linked degrons and degronimers for protein degradation
#10System and method of wagering on a plurality of events
#11NOVEL HEADGROUP LIPID COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS
#12Compositions and methods for viral sensitization
#13INHIBITORS OF IRES-MEDIATED PROTEIN SYNTHESIS
#14AMINOBENZOIC ACID DERIVATIVES FOR USE AS ANTI-INFLAMMATORY AGENTS, ANTI-METASTATIC AGENTS AND/OR ANTICANCER AGENTS
#15Compositions and methods for viral sensitization
#16GLYCOLATE OXIDASE INHIBITORS AND METHODS OF USE FOR THE TREATMENT OF KIDNEY STONES
#17N/O-linked Degrons and Degronimers for protein degradation
#18Reversible covalent linkage of functional molecules
#19Type III deiodinase inhibitors and uses thereof
#20Di-substituted maleic amide linker for antibody drug conjugating and preparation method and use thereof
#21Antibody-drug conjugates and the use of same in therapy
#22Reversible covalent linkage of functional molecules
#23Aminobenzoic acid derivatives for use as anti-inflammatory agents, anti-metastatic agents and/or anticancer agents
#24Phenyl, bromo-maleimide as a coupling group for conjugation to sulfhydryl group
#25COMPOSITIONS AND METHODS FOR ENHANCING ONCOLYTIC VIRUS EFFICACY
#26Method for producing pyrrole derivative, and intermediate thereof
#27Type III deiodinase inhibitors and uses thereof
#28Compositions and methods for viral sensitization
#29Boron-dipyrrin complex and medicament containing the same
#30Method for producing pyrrole derivative, and intermediate thereof
#31Method for producing pyrrole derivative, and intermediate thereof
#32Reversible covalent linkage of functional molecules
#33Antibody-drug conjugates and the use of same in therapy
#34Methods and compositions involving RAD51 inhibitors
#35Method for inhibiting differentiation of osteoclast and pharmaceutical composition comprising thereof
#36METHOD FOR PRODUCING DITHINE TETRACARBOXIMIDES
#37New compounds for inhibiting differentiation of osteoclast and pharmaceutical composition comprising thereof
#38Polyoxyalkylene-modified lipid and method for producing the same
#39Thiol Protecting Group
#40Functionalisation of Solid Substrates
#41Reversible covalent linkage of functional molecules
#42Process for preparing dithiine-tetracarboxy-diimides
#43Process for preparing dithiine-tetracarboximides
#44Heterocyclic amide compounds useful as kinase inhibitors
#45Latrunculin-Based Macrolides and Their Uses
#46Compounds that modulate intracellular calcium
#47Nanoparticle conjugates
#48Process for the production of amorphous atorvastatin calcium
#49Trityl derivatives for enhancing mass spectrometry
#50Phenylazo-acetoacetanilide derivatives with a polymerizable functional group and related compounds as monomers for preparing polymeric pigment dispersants for inkjet inks
#51Heterocyclic amide compounds useful as kinase inhibitors
#52Maleiimide anti-tumor phosphatase inhibitors
#53Enzyme inhibitors
#54Nanoparticle conjugates
#55Pyrrole-2,5-dione derivatives as Liver X receptor modulators
#56Tyrosine kinase inhibitors
#57Scaffolded maleimide clusters for multivalent peptide assembly
#58Halogenated styrene compounds and very low-loss polymers made therefrom
#59Enzyme inhibitors